Share on StockTwits

Hill-Rom Holdings (NYSE:HRC)‘s stock had its “underweight” rating reaffirmed by Morgan Stanley in a research note issued on Friday, AnalystRatings.Net reports. They currently have a $36.00 target price on the stock. Morgan Stanley’s price target indicates a potential downside of 3.46% from the company’s current price.

The analysts wrote, “Sales remained pressured in F2Q14, declining 3% on a -8% comp, stable sequentially on a comp-adjusted basis. This is consistent with the end-market pressures we discussed in our November 11 downgrade report, End-market Pressure Too Great; Downgrading to UW. Hill-Rom’s earnings beat was driven by better than expected operating margins, which increased y/y for the first time in six quarters. While guidance for the year remained mostly unchanged after adjusting for Hill-Rom’s exit of the home care business, F3Q14 guidance was below street and MS expectations. “We continue to believe that the company’s structurally weak capital end-markets will cause slower growth and more volatile results than peers, and given headwinds from growth, mix, and quality spending, Hill-Rom’s Long-Range Plan of 300-400 bps of EBIT margin expansion may prove challenging.”

Hill-Rom Holdings (NYSE:HRC) traded up 2.15% on Friday, hitting $38.09. The stock had a trading volume of 239,090 shares. Hill-Rom Holdings has a 52-week low of $32.74 and a 52-week high of $44.64. The stock has a 50-day moving average of $37.66 and a 200-day moving average of $39.19. The company has a market cap of $2.188 billion and a price-to-earnings ratio of 23.71.

Hill-Rom Holdings (NYSE:HRC) last released its earnings data on Friday, May 2nd. The company reported $0.57 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.51 by $0.06. The company had revenue of $415.00 million for the quarter, compared to the consensus estimate of $412.02 million. Analysts expect that Hill-Rom Holdings will post $2.22 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Northcoast Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “neutral” rating in a research note on Friday, April 11th. Separately, analysts at KeyCorp initiated coverage on shares of Hill-Rom Holdings in a research note on Wednesday, April 9th. They set a “hold” rating on the stock. Finally, analysts at Ned Davis Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “neutral” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $39.73.

Hill-Rom Holdings, Inc (NYSE:HRC) is a manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.